Aspergillus
FDA Label NDC 54256-029

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bioresource Inc. for the product Aspergillus (NDC 54256-029). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - purpose, inactive ingredient, dosage, warning, otc - keep out of reach of children, tamper evident, other, principal display panel - 10 suppository blister pack box, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Purpose

For treatment of lymphatic stagnation.

Inactive Ingredient

182 mg Aspergillus niger 3X with sodium chloride in a base of mono-, di-, triglycerides (hard fat).

Dosage

Insert one suppository rectally each night before bed.

Warning

If symptoms persist more than a few days, contact a licensed practitioner. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before using this product.

Otc - Keep Out Of Reach Of Children

Keep this and all medications out of the reach of children. Protect from light and heat.

Tamper Evident

Use this product only if inner blister pack is intact.

To report adverse events, contact BioResource at 707/664-9023 or [email protected]

Other

Distributed By:
BioResource Inc.
Cotati CA 94931

Principal Display Panel - 10 Suppository Blister Pack Box

SanPharma™
Aspergillus
Suppositories 3X

Homeopathic
Medicine

For lymphatic stagnation

RX

10 SUPPOSITORIES

SanPharma ™

Principal Display Panel (10 Suppository Blister Pack Box)

Principal Display Panel (10 Suppository Blister Pack Box)

* Please review the disclaimer below.